{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T08:28:36Z","timestamp":1793780916427,"version":"4.6.1"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"8","funder":[{"name":"Division of STD Prevention"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Chlamydia trachomatis causes pelvic inflammatory disease (PID) and tubal infertility. Plasmid gene protein 3 antibody (Pgp3Ab) detects prior chlamydial infections. We evaluated for an association of high chlamydial seropositivity with sequelae using a Pgp3Ab multiplex bead array (Pgp3AbMBA).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We performed chlamydia Pgp3AbMBA on sera from women 18-39 years old participating in the 2013\u20132016 National Health and Nutrition Examination Survey (NHANES) with urine chlamydia nucleic acid amplification test results. High chlamydial seropositivity was defined as a median fluorescence intensity (MFI\u2005\u2265\u200550 000; low-positive was MFI\u2005&amp;gt;\u2005551\u2013&amp;lt;50 000. Weighted US population high-positive, low-positive, and negative Pgp3Ab chlamydia seroprevalence and 95% confidence intervals (CI) were compared for women with chlamydial infection, self-reported PID, and infertility.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 2339 women aged 18\u201339 years, 1725 (73.7%) had sera, and 1425 were sexually experienced. Overall, 104 women had high positive Pgp3Ab (5.4% [95% CI 4.0\u20137.0] of US women); 407 had lowpositive Pgp3Ab (25.1% [95% CI 21.5\u201329.0]), and 914 had negative Pgp3Ab (69.5% [95% CI 65.5\u201373.4]). Among women with high Pgp3Ab, infertility prevalence was 2.0 (95% CI 1.1\u20133.7) times higher than among Pgp3Ab-negative women (19.6% [95% CI 10.5\u201331.7] versus 9.9% [95% CI 7.7\u201312.4]). For women with low Pgp3Ab, PID prevalence was 7.9% (95% CI 4.6\u201312.6) compared to 2.3% (95% CI 1.4\u20133.6) in negative Pgp3Ab.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>High chlamydial Pgp3Ab seropositivity was associated with infertility although small sample size limited evaluation of an association of high seropositivity with PID. In infertile women, Pgp3Ab may be a marker of prior chlamydial infection.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciab506","type":"journal-article","created":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T19:48:20Z","timestamp":1622231300000},"page":"1507-1516","source":"Crossref","is-referenced-by-count":18,"title":["High Plasmid Gene Protein 3 (Pgp3) <i>Chlamydia trachomatis<\/i> Seropositivity, Pelvic Inflammatory Disease, and Infertility Among Women, National Health and Nutrition Examination Survey, United States, 2013\u20132016"],"prefix":"10.1093","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7911-1701","authenticated-orcid":false,"given":"Gloria E","family":"Anyalechi","sequence":"first","affiliation":[{"name":"Division of Sexually Transmitted Diseases (STD) Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeyoung","family":"Hong","sequence":"additional","affiliation":[{"name":"Division of Sexually Transmitted Diseases (STD) Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien C","family":"Danavall","sequence":"additional","affiliation":[{"name":"Division of Sexually Transmitted Diseases (STD) Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana L","family":"Martin","sequence":"additional","affiliation":[{"name":"Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E","family":"Gwyn","sequence":"additional","affiliation":[{"name":"Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J","family":"Horner","sequence":"additional","affiliation":[{"name":"Population Health Sciences and National Institute for Health Research, Health Protection Research Unit in Behavioural Science and Evaluation in Partnership with Public Health England, University of Bristol, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian H","family":"Raphael","sequence":"additional","affiliation":[{"name":"Division of Sexually Transmitted Diseases (STD) Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D","family":"Kirkcaldy","sequence":"additional","affiliation":[{"name":"Division of Sexually Transmitted Diseases (STD) Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen N","family":"Kersh","sequence":"additional","affiliation":[{"name":"Division of Sexually Transmitted Diseases (STD) Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle T","family":"Bernstein","sequence":"additional","affiliation":[{"name":"Division of Sexually Transmitted Diseases (STD) Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,5,29]]},"reference":[{"key":"2021102017443342400_CIT0001","volume-title":"Sexually transmitted disease surveillance 2018","author":"Centers for Disease Control and Prevention.","year":"2019"},{"key":"2021102017443342400_CIT0002","article-title":"Seroprevalence of Chlamydia trachomatis among female adults in the United States: the National Health and Nutrition Examination Surveys","author":"Petersen","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2021102017443342400_CIT0003","doi-asserted-by":"crossref","first-page":"c1642","DOI":"10.1136\/bmj.c1642","article-title":"Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial","volume":"340","author":"Oakeshott","year":"2010","journal-title":"BMJ"},{"key":"2021102017443342400_CIT0004","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00007435-199207000-00001","article-title":"Pelvic inflammatory disease and fertility: a cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results","volume":"19","author":"Westr\u00f6m","year":"1992","journal-title":"Sex Transm Dis"},{"key":"2021102017443342400_CIT0005","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1136\/sextrans-2011-050386","article-title":"Effect of time since exposure to Chlamydia trachomatis on chlamydia antibody detection in women: a cross-sectional study","volume":"89","author":"Horner","year":"2013","journal-title":"Sex Transm Infect"},{"key":"2021102017443342400_CIT0006","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00007435-199511000-00007","article-title":"The influence of sexual and social factors on the risk of Chlamydia trachomatis infections: a population-based serologic study","volume":"22","author":"Jonsson","year":"1995","journal-title":"Sex Transm Dis"},{"key":"2021102017443342400_CIT0007","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1258\/ijsa.2008.008489","article-title":"Further observations, mainly serological, on a cohort of women with or without pelvic inflammatory disease","volume":"20","author":"Taylor-Robinson","year":"2009","journal-title":"Int J STD AIDS"},{"key":"2021102017443342400_CIT0008","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/OLQ.0b013e3181557c25","article-title":"Chlamydia antibodies, chlamydia heat shock protein, and adverse sequelae after pelvic inflammatory disease: the PID evaluation and clinical health (PEACH) study","volume":"35","author":"Ness","year":"2008","journal-title":"Sex Transm Dis"},{"key":"2021102017443342400_CIT0009","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/infdis\/jiv438","article-title":"Analysis of factors driving incident and ascending infection and the role of serum antibody in Chlamydia trachomatis genital tract infection","volume":"213","author":"Russell","year":"2016","journal-title":"J Infect Dis"},{"key":"2021102017443342400_CIT0010","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/aje\/kww117","article-title":"Proportion of tubal factor infertility due to chlamydia: finite mixture modeling of serum antibody titers","volume":"185","author":"Ades","year":"2017","journal-title":"Am J Epidemiol"},{"key":"2021102017443342400_CIT0011","doi-asserted-by":"crossref","first-page":"336.e1","DOI":"10.1016\/j.ajog.2017.05.026","article-title":"Population-attributable fraction of tubal factor infertility associated with chlamydia","volume":"217","author":"Gorwitz","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"2021102017443342400_CIT0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta20220","article-title":"The natural history of Chlamydia trachomatis infection in women: a multi-parameter evidence synthesis","volume":"20","author":"Price","year":"2016","journal-title":"Health Technol Assess"},{"key":"2021102017443342400_CIT0013","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.4269\/ajtmh.17-0292","article-title":"Comparison of platforms for testing antibody responses against the Chlamydia trachomatis antigen Pgp3","volume":"97","author":"Gwyn","year":"2017","journal-title":"Am J Trop Med Hyg"},{"key":"2021102017443342400_CIT0014","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1177\/0956462418785244","article-title":"Comparison of three serological assays to measure antibody response to Chlamydia antigen Pgp3 in adolescent and young adults with pelvic inflammatory disease","volume":"29","author":"Dize","year":"2018","journal-title":"Int J STD AIDS"},{"key":"2021102017443342400_CIT0015","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1128\/IAI.02576-14","article-title":"Plasmid-encoded Pgp3 is a major virulence factor for Chlamydia muridarum to induce hydrosalpinx in mice","volume":"82","author":"Liu","year":"2014","journal-title":"Infect Immun"},{"key":"2021102017443342400_CIT0016","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0264-410X(02)00631-X","article-title":"DNA immunization with pgp3 gene of Chlamydia trachomatis inhibits the spread of chlamydial infection from the lower to the upper genital tract in C3H\/HeN mice","volume":"21","author":"Donati","year":"2003","journal-title":"Vaccine"},{"key":"2021102017443342400_CIT0017","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.fertnstert.2015.08.022","article-title":"Chlamydia trachomatis immunoglobulin G3 seropositivity is a predictor of reproductive outcomes in infertile women with patent fallopian tubes","volume":"104","author":"Steiner","year":"2015","journal-title":"Fertil Steril"},{"key":"2021102017443342400_CIT0018","volume-title":"Sexually transmitted diseases","author":"Holmes","year":"2007","edition":"4th ed"},{"key":"2021102017443342400_CIT0019","doi-asserted-by":"crossref","first-page":"e399","DOI":"10.1016\/S1473-3099(18)30159-2","article-title":"Advancing the public health applications of Chlamydia trachomatis serology","volume":"18","author":"Woodhall","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2021102017443342400_CIT0020","author":"Centers for Disease Control and Prevention\u2014National Center for Health Statistics"},{"key":"2021102017443342400_CIT0021","author":"Centers for Disease Control and Prevention\u2014National Center for Health Statistics"},{"key":"2021102017443342400_CIT0022","doi-asserted-by":"crossref","first-page":"e1873","DOI":"10.1371\/journal.pntd.0001873","article-title":"CT694 and pgp3 as serological tools for monitoring trachoma programs","volume":"6","author":"Goodhew","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"2021102017443342400_CIT0023","author":"Centers for Disease Control and Prevention\u2014National Center for Health Statistics"},{"key":"2021102017443342400_CIT0024","author":"Centers for Disease Control and Prevention\u2014National Center for Health Statistics"},{"key":"2021102017443342400_CIT0025","author":"Centers for Disease Control and Prevention\u2014National Center for Health Statistics"},{"key":"2021102017443342400_CIT0026","doi-asserted-by":"crossref","first-page":"ftz031","DOI":"10.1093\/femspd\/ftz031","article-title":"Evaluation of a PGP3 ELISA for surveillance of the burden of Chlamydia infection in women from Australia and Samoa","volume":"77","author":"Mazraani","year":"2019","journal-title":"Pathog Dis"},{"key":"2021102017443342400_CIT0027","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12879-016-1508-0","article-title":"Sero-epidemiological assessment of Chlamydia trachomatis infection and sub-fertility in Samoan women","volume":"16","author":"Menon","year":"2016","journal-title":"BMC Infect Dis"},{"key":"2021102017443342400_CIT0028","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1128\/CMR.00035-15","article-title":"Human and pathogen factors associated with Chlamydia trachomatis-related infertility in women","volume":"28","author":"Menon","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"2021102017443342400_CIT0029","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1093\/humrep\/deg347","article-title":"Tubal damage in infertile women: prediction using chlamydia serology","volume":"18","author":"Akande","year":"2003","journal-title":"Hum Reprod"},{"key":"2021102017443342400_CIT0030","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00007435-199503000-00001","article-title":"Tubal infertility: serologic relationship to past chlamydial and gonococcal infection. World Health Organization Task Force on the Prevention and Management of Infertility","volume":"22","year":"1995","journal-title":"Sex Transm Dis"},{"key":"2021102017443342400_CIT0031","doi-asserted-by":"crossref","first-page":"e13051","DOI":"10.1111\/aji.13051","article-title":"Predicting tubal factor infertility by using markers of humoral and cell-mediated immune response against Chlamydia trachomatis","volume":"80","author":"Rantsi","year":"2018","journal-title":"Am J Reprod Immunol"},{"key":"2021102017443342400_CIT0032","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/00001703-200406000-00004","article-title":"Evidence-based diagnosis and management of tubal factor infertility","volume":"16","author":"Kodaman","year":"2004","journal-title":"Curr Opin Obstet Gynecol"},{"key":"2021102017443342400_CIT0033","doi-asserted-by":"crossref","first-page":"e0151497","DOI":"10.1371\/journal.pone.0151497","article-title":"Chlamydia trachomatis Pgp3 antibody persists and correlates with self-reported infection and behavioural risks in a blinded cohort study","volume":"11","author":"Horner","year":"2016","journal-title":"PLoS One"},{"key":"2021102017443342400_CIT0034","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1136\/sextrans-2018-053915","article-title":"Prevalence and persistence of Chlamydia trachomatis-specific antibodies after occasional and recurrent infections","volume":"96","author":"\u00d6hman","year":"2020","journal-title":"Sex Transm Infect"},{"key":"2021102017443342400_CIT0035","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa101","article-title":"A randomized controlled trial of ceftriaxone and doxycycline, with or without metronidazole, for the treatment of acute pelvic inflammatory disease","author":"Wiesenfeld","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2021102017443342400_CIT0036","doi-asserted-by":"crossref","first-page":"393.e1","DOI":"10.1016\/j.ajog.2016.12.005","article-title":"Validity of self-reported history of Chlamydia trachomatis infection","volume":"216","author":"Frisse","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"2021102017443342400_CIT0037","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/OLQ.0000000000000605","article-title":"Chlamydia trachomatis incidence using self-reports and serology by gender, age period, and sexual behavior in a birth cohort","volume":"44","author":"Righarts","year":"2017","journal-title":"Sex Transm Dis"},{"key":"2021102017443342400_CIT0038","first-page":"834","article-title":"Prevalence of Chlamydia trachomatis genital infection among persons aged 14\u201339 years-United States, 2007\u20132012","volume":"63","author":"Torrone","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciab506\/39278481\/ciab506.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/73\/8\/1507\/40786373\/ciab506.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/73\/8\/1507\/40786373\/ciab506.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T01:01:37Z","timestamp":1634778097000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/73\/8\/1507\/6288470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,29]]},"references-count":38,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,5,29]]},"published-print":{"date-parts":[[2021,10,20]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciab506","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,10,15]]},"published":{"date-parts":[[2021,5,29]]}}}